Showing results (531-540 of 6,291) with videos related to

Sort By:
Pageof 630
Open Forum Infectious Diseases|September 1, 2021
Aspergillus lentulus: An Under-recognized Cause of Antifungal Drug-Resistant AspergillosisSaman Nematollahi, Nitipong Permpalung, Sean X Zhang, et al.
Open Forum Infectious Diseases|August 11, 2021
Dynamic Change and Clinical Relevance of Postinfectious SARS-CoV-2 Antibody ResponsesPatrick W G Mallon, Willard Tinago, Alejandro Garcia Leon, et al.
Open Forum Infectious Diseases|August 11, 2021
Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the ClinicianImad M Tleyjeh, Tarek Kashour, Jay Mandrekar, et al.
Open Forum Infectious Diseases|August 11, 2021
Absence of Antibody Reponses and Severe COVID-19 in Patients on Hemodialysis Following mRNA VaccinationMiriam B Michael, Siham M Mahgoub, Reiad Khan, et al.
Open Forum Infectious Diseases|August 11, 2021
Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated IndividualSolen Kernéis, Delphine Planas, Sandrine Imbeaud, et al.
Open Forum Infectious Diseases|August 11, 2021
Health Care Workers' Attitudes Toward Patients With COVID-19Joseph Ottolenghi, Rodney A McLaren, Cecilia Bahamon, et al.
Open Forum Infectious Diseases|August 16, 2021
Association of Physician Orders for Life-Sustaining Treatment With Inpatient Antimicrobial Use at End of Life in Patients With CancerOlivia S Kates, Elizabeth M Krantz, Juhye Lee, et al.
Open Forum Infectious Diseases|August 16, 2021
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)Adam G Stewart, David L Paterson, Barnaby Young, et al.
Open Forum Infectious Diseases|August 16, 2021
Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue DiseaseMichael J Peluso, Sadie E Munter, Kara L Lynch, et al.
Open Forum Infectious Diseases|August 3, 2022
Impact of a Laboratory-Developed Phenotypic Rapid Susceptibility Test Directly From Positive Blood Cultures on Time to Narrowest Effective Therapy in Patients With Gram-Negative Bacteremia: A Prospective Randomized TrialAlyssa B Christensen, Brent Footer, Tobias Pusch, et al.
Pageof 630